Mouheb, A., Metzger, M., Pinho, N. A. D., Jacquelinet, C., Laville, M., Massy, Z. A., Liabeuf, S., Laville, S. M., Cannet, D., Combe, C., Fouque, D., Hamroun, A., Herpe, Y., Lambert, O., Lange, C., Morel, P., Pascal, C., Pecoits-Filho, R., Schantsra, J., Stengel, B., Hannedouche, T., Moulin, B., Klein, A., Combe, C., Bourdenx, J. P., Keller, A., Delclaux, C., Vendrely, B., Deroure, B., Lacraz, A., Lobbedez, T., Landru, I., Massy, Z., Lang, P., Belenfant, X., Thervet, E., Urena, P., Delahousse, M., Vela, C., Essig, M., Clément, D., Sekhri, H., Smati, M., Jamali, M., Hacq, B., Panescu, V., Bellou, M., Frimat, L., Kamar, N., Noël, C., Glowacki, F., Maisonneuve, N., Azar, R., Hoffmann, M., Hourmant, M., Testa, A., Besnier, D., Choukroun, G., Lambrey, G., Burtey, S., Lebrun, G., Magnant, E., Laville, M., Fouque, D., Juillard, L., Chazot, C., Zaoui, P., Kuentz, F. (2026). Hyperpolypharmacy in patients with chronic kidney disease and its impact on clinical outcomes. Scientific Reports. https://doi.org/10.1038/s41598-025-25632-x